Skip to main content

. 1964 Nov 7;2(5418):1177–1178. doi: 10.1136/bmj.2.5418.1177

Multiple Deficiency State Associated with Isoniazid Therapy

PMCID: PMC1816708 PMID: 14190490

1177

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BIEHL J. P., VILTER R. W. Effects of isoniazid on pyridoxine metabolism. J Am Med Assoc. 1954 Dec 25;156(17):1549–1552. doi: 10.1001/jama.1954.02950170003002. [DOI] [PubMed] [Google Scholar]
DEVADATTA S., GANGADHARAM P. R., ANDREWS R. H., FOX W., RAMAKRISHNAN C. V., SELKON J. B., VELU S. Peripheral neuritis due to isoniazid. Bull World Health Organ. 1960;23:587–598. [PMC free article] [PubMed] [Google Scholar]
HAYNES W. S. Pellagra occurring in Africans under treatment for pulmonary tuberculosis. East Afr Med J. 1958 Apr;35(4):171–180. [PubMed] [Google Scholar]
JACKSON S. L. Psychosis due to isoniazid. Br Med J. 1957 Sep 28;2(5047):743–746. doi: 10.1136/bmj.2.5047.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
SALZER H. M., LURIE M. L. Anxiety and depressive states treated with isonicotinyl hydrazide (isoniazid). AMA Arch Neurol Psychiatry. 1953 Sep;70(3):317–324. doi: 10.1001/archneurpsyc.1953.02320330042005. [DOI] [PubMed] [Google Scholar]
WOOD M. M. Central nervous system complications during I.N.H. treatment of pulmonary tuberculosis. Br J Tuberc Dis Chest. 1955 Jan;49(1):20–29. doi: 10.1016/s0366-0869(55)80005-6. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES